2015-2027 Global Doxorubicin Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

June 2020 | 139 pages | ID: 2A0FB4D7C794EN
Maia Research

Abstracts

The worldwide market for Doxorubicin is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Pfizer
Sun Pharmaceutical Industries
Sterling
MicroBiopharm Japan
Synbias Pharma
Boryung
Teva
Meiji Seika Pharma
Johnson & Johnson
LINGNAN Pharmaceutical

Major Types Covered
Doxorubicin Injection 10mg
Doxorubicin Injection 50mg

Major Applications Covered
Multiple Myeloma
Kaposi Sarcoma
Leukemia

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Doxorubicin Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Doxorubicin Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE DOXORUBICIN MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL DOXORUBICIN MARKET-SEGMENTATION BY TYPE

5.1 Doxorubicin Injection 10mg
5.2 Doxorubicin Injection 50mg

6 GLOBAL DOXORUBICIN MARKET-SEGMENTATION BY APPLICATION

6.1 Multiple Myeloma
6.2 Kaposi Sarcoma
6.3 Leukemia

7 GLOBAL DOXORUBICIN MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Pfizer
  8.1.1 Pfizer Profile
  8.1.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Pfizer Product/Solution Launches and Enhancements Analysis
  8.1.4 Pfizer Business Overview/Recent Development/Acquisitions
8.2 Sun Pharmaceutical Industries
  8.2.1 Sun Pharmaceutical Industries Profile
  8.2.2 Sun Pharmaceutical Industries Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Sun Pharmaceutical Industries Product/Solution Launches and Enhancements Analysis
  8.2.4 Sun Pharmaceutical Industries Business Overview/Recent Development/Acquisitions
8.3 Sterling
  8.3.1 Sterling Profile
  8.3.2 Sterling Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Sterling Product/Solution Launches and Enhancements Analysis
  8.3.4 Sterling Business Overview/Recent Development/Acquisitions
8.4 MicroBiopharm Japan
  8.4.1 MicroBiopharm Japan Profile
  8.4.2 MicroBiopharm Japan Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 MicroBiopharm Japan Product/Solution Launches and Enhancements Analysis
  8.4.4 MicroBiopharm Japan Business Overview/Recent Development/Acquisitions
8.5 Synbias Pharma
  8.5.1 Synbias Pharma Profile
  8.5.2 Synbias Pharma Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Synbias Pharma Product/Solution Launches and Enhancements Analysis
  8.5.4 Synbias Pharma Business Overview/Recent Development/Acquisitions
8.6 Boryung
  8.6.1 Boryung Profile
  8.6.2 Boryung Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Boryung Product/Solution Launches and Enhancements Analysis
  8.6.4 Boryung Business Overview/Recent Development/Acquisitions
8.7 Teva
  8.7.1 Teva Profile
  8.7.2 Teva Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Teva Product/Solution Launches and Enhancements Analysis
  8.7.4 Teva Business Overview/Recent Development/Acquisitions
8.8 Meiji Seika Pharma
  8.8.1 Meiji Seika Pharma Profile
  8.8.2 Meiji Seika Pharma Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Meiji Seika Pharma Product/Solution Launches and Enhancements Analysis
  8.8.4 Meiji Seika Pharma Business Overview/Recent Development/Acquisitions
8.9 Johnson & Johnson
  8.9.1 Johnson & Johnson Profile
  8.9.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
  8.9.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
  8.9.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
8.10 LINGNAN Pharmaceutical
  8.10.1 LINGNAN Pharmaceutical Profile
  8.10.2 LINGNAN Pharmaceutical Sales, Growth Rate and Global Market Share from 2015-2020
  8.10.3 LINGNAN Pharmaceutical Product/Solution Launches and Enhancements Analysis
  8.10.4 LINGNAN Pharmaceutical Business Overview/Recent Development/Acquisitions

9 GLOBAL DOXORUBICIN MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Doxorubicin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Doxorubicin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Doxorubicin Production Analysis from 2015-2020
10.4 North America Doxorubicin Consumption Analysis from 2015-2020
10.5 North America Doxorubicin Import and Export from 2015-2020
10.6 North America Doxorubicin Value, Production and Market Share by Type (2015-2020)
10.7 North America Doxorubicin Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Doxorubicin by Country (United States, Canada)
  10.8.1 North America Doxorubicin Sales by Country (2015-2020)
  10.8.2 North America Doxorubicin Consumption Value by Country (2015-2020)
10.9 North America Doxorubicin Market PEST Analysis

11 EUROPE

11.1 Europe Doxorubicin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Doxorubicin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Doxorubicin Production Analysis from 2015-2020
11.4 Europe Doxorubicin Consumption Analysis from 2015-2020
11.5 Europe Doxorubicin Import and Export from 2015-2020
11.6 Europe Doxorubicin Value, Production and Market Share by Type (2015-2020)
11.7 Europe Doxorubicin Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Doxorubicin by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Doxorubicin Sales by Country (2015-2020)
  11.8.2 Europe Doxorubicin Consumption Value by Country (2015-2020)
11.9 Europe Doxorubicin Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Doxorubicin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Doxorubicin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Doxorubicin Production Analysis from 2015-2020
12.4 Asia-Pacific Doxorubicin Consumption Analysis from 2015-2020
12.5 Asia-Pacific Doxorubicin Import and Export from 2015-2020
12.6 Asia-Pacific Doxorubicin Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Doxorubicin Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Doxorubicin by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Doxorubicin Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Doxorubicin Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Doxorubicin Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Doxorubicin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Doxorubicin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Doxorubicin Production Analysis from 2015-2020
13.4 Latin America Doxorubicin Consumption Analysis from 2015-2020
13.5 Latin America Doxorubicin Import and Export from 2015-2020
13.6 Latin America Doxorubicin Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Doxorubicin Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Doxorubicin by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Doxorubicin Sales by Country (2015-2020)
  13.8.2 Latin America Doxorubicin Consumption Value by Country (2015-2020)
13.9 Latin America Doxorubicin Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Doxorubicin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Doxorubicin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Doxorubicin Production Analysis from 2015-2020
14.4 Middle East & Africa Doxorubicin Consumption Analysis from 2015-2020
14.5 Middle East & Africa Doxorubicin Import and Export from 2015-2020
14.6 Middle East & Africa Doxorubicin Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Doxorubicin Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Doxorubicin by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Doxorubicin Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Doxorubicin Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Doxorubicin Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL DOXORUBICIN MARKET FROM 2020-2027

15.1 Future Forecast of the Global Doxorubicin Market from 2020-2027 Segment by Region
15.2 Global Doxorubicin Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Doxorubicin Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Doxorubicin Market Value ($) and Growth Rate of Doxorubicin from 2015-2027
Global Doxorubicin Production and Growth Rate Segment by Product Type from 2015-2027
Global Doxorubicin Consumption and Growth Rate Segment by Application from 2015-2027
Figure Doxorubicin Picture
Table Product Specifications of Doxorubicin
Table Driving Factors for this Market
Table Industry News of Doxorubicin Market
Figure Value Chain Status of Doxorubicin
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Doxorubicin Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Doxorubicin Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Doxorubicin Injection 10mg of Doxorubicin
Figure Doxorubicin Injection 50mg of Doxorubicin
Table Global Doxorubicin Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Doxorubicin Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Multiple Myeloma of Doxorubicin
Figure Kaposi Sarcoma of Doxorubicin
Figure Leukemia of Doxorubicin
Table Global Doxorubicin Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Doxorubicin Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Doxorubicin
Figure Online Channel of Doxorubicin
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Doxorubicin Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sun Pharmaceutical Industries Profile (Company Name, Plants Distribution, Sales Region)
Figure Sun Pharmaceutical Industries Sales and Growth Rate from 2015-2020
Figure Sun Pharmaceutical Industries Revenue ($) and Global Market Share from 2015-2020
Table Sun Pharmaceutical Industries Doxorubicin Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sterling Profile (Company Name, Plants Distribution, Sales Region)
Figure Sterling Sales and Growth Rate from 2015-2020
Figure Sterling Revenue ($) and Global Market Share from 2015-2020
Table Sterling Doxorubicin Sales, Price, Revenue, Gross Margin (2015-2020)
Table MicroBiopharm Japan Profile (Company Name, Plants Distribution, Sales Region)
Figure MicroBiopharm Japan Sales and Growth Rate from 2015-2020
Figure MicroBiopharm Japan Revenue ($) and Global Market Share from 2015-2020
Table MicroBiopharm Japan Doxorubicin Sales, Price, Revenue, Gross Margin (2015-2020)
Table Synbias Pharma Profile (Company Name, Plants Distribution, Sales Region)
Figure Synbias Pharma Sales and Growth Rate from 2015-2020
Figure Synbias Pharma Revenue ($) and Global Market Share from 2015-2020
Table Synbias Pharma Doxorubicin Sales, Price, Revenue, Gross Margin (2015-2020)
Table Boryung Profile (Company Name, Plants Distribution, Sales Region)
Figure Boryung Sales and Growth Rate from 2015-2020
Figure Boryung Revenue ($) and Global Market Share from 2015-2020
Table Boryung Doxorubicin Sales, Price, Revenue, Gross Margin (2015-2020)
Table Teva Profile (Company Name, Plants Distribution, Sales Region)
Figure Teva Sales and Growth Rate from 2015-2020
Figure Teva Revenue ($) and Global Market Share from 2015-2020
Table Teva Doxorubicin Sales, Price, Revenue, Gross Margin (2015-2020)
Table Meiji Seika Pharma Profile (Company Name, Plants Distribution, Sales Region)
Figure Meiji Seika Pharma Sales and Growth Rate from 2015-2020
Figure Meiji Seika Pharma Revenue ($) and Global Market Share from 2015-2020
Table Meiji Seika Pharma Doxorubicin Sales, Price, Revenue, Gross Margin (2015-2020)
Table Johnson & Johnson Profile (Company Name, Plants Distribution, Sales Region)
Figure Johnson & Johnson Sales and Growth Rate from 2015-2020
Figure Johnson & Johnson Revenue ($) and Global Market Share from 2015-2020
Table Johnson & Johnson Doxorubicin Sales, Price, Revenue, Gross Margin (2015-2020)
Table LINGNAN Pharmaceutical Profile (Company Name, Plants Distribution, Sales Region)
Figure LINGNAN Pharmaceutical Sales and Growth Rate from 2015-2020
Figure LINGNAN Pharmaceutical Revenue ($) and Global Market Share from 2015-2020
Table LINGNAN Pharmaceutical Doxorubicin Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Doxorubicin Production Value ($) by Region from 2015-2020
Table Global Doxorubicin Production Value Share by Region from 2015-2020
Table Global Doxorubicin Production by Region from 2015-2020
Table Global Doxorubicin Consumption Value ($) by Region from 2015-2020
Table Global Doxorubicin Consumption by Region from 2015-2020
Table North America Doxorubicin Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Doxorubicin Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Doxorubicin Import and Export from 2015-2020
Table North America Doxorubicin Value ($) by Type (2015-2020)
Table North America Doxorubicin Production by Type (2015-2020)
Table North America Doxorubicin Consumption by Application (2015-2020)
Table North America Doxorubicin Consumption by Country (2015-2020)
Table North America Doxorubicin Consumption Value ($) by Country (2015-2020)
Figure North America Doxorubicin Market PEST Analysis
Table Europe Doxorubicin Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Doxorubicin Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Doxorubicin Import and Export from 2015-2020
Table Europe Doxorubicin Value ($) by Type (2015-2020)
Table Europe Doxorubicin Production by Type (2015-2020)
Table Europe Doxorubicin Consumption by Application (2015-2020)
Table Europe Doxorubicin Consumption by Country (2015-2020)
Table Europe Doxorubicin Consumption Value ($) by Country (2015-2020)
Figure Europe Doxorubicin Market PEST Analysis
Table Asia-Pacific Doxorubicin Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Doxorubicin Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Doxorubicin Import and Export from 2015-2020
Table Asia-Pacific Doxorubicin Value ($) by Type (2015-2020)
Table Asia-Pacific Doxorubicin Production by Type (2015-2020)
Table Asia-Pacific Doxorubicin Consumption by Application (2015-2020)
Table Asia-Pacific Doxorubicin Consumption by Country (2015-2020)
Table Asia-Pacific Doxorubicin Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Doxorubicin Market PEST Analysis
Table Latin America Doxorubicin Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Doxorubicin Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Doxorubicin Import and Export from 2015-2020
Table Latin America Doxorubicin Value ($) by Type (2015-2020)
Table Latin America Doxorubicin Production by Type (2015-2020)
Table Latin America Doxorubicin Consumption by Application (2015-2020)
Table Latin America Doxorubicin Consumption by Country (2015-2020)
Table Latin America Doxorubicin Consumption Value ($) by Country (2015-2020)
Figure Latin America Doxorubicin Market PEST Analysis
Table Middle East & Africa Doxorubicin Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Doxorubicin Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Doxorubicin Import and Export from 2015-2020
Table Middle East & Africa Doxorubicin Value ($) by Type (2015-2020)
Table Middle East & Africa Doxorubicin Production by Type (2015-2020)
Table Middle East & Africa Doxorubicin Consumption by Application (2015-2020)
Table Middle East & Africa Doxorubicin Consumption by Country (2015-2020)
Table Middle East & Africa Doxorubicin Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Doxorubicin Market PEST Analysis
Table Global Doxorubicin Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Doxorubicin Production and Growth Rate Forecast by Region (2020-2027)
Table Global Doxorubicin Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Doxorubicin Production and Growth Rate Forecast by Type (2020-2027)
Table Global Doxorubicin Consumption and Growth Rate Forecast by Application (2020-2027)